Federal Cannabis Rescheduling: Status, Impacts, And Strategies

Recent reports indicate that President Trump is preparing to issue an executive order as early as Monday, December 15 directing his administration to finalize the long-anticipated reclassification of cannabis under the federal Controlled Substances Act (CSA) from Schedule I to Schedule III. This development follows years of regulatory review and political debate spanning multiple administrations and would mark the most significant federal cannabis policy shift in more than 50 years.

Where the Rescheduling Process Stands

Under the current federal framework, cannabis remains a CSA Schedule I substance, a category reserved for drugs the government deems to have a "high potential for abuse" and "no accepted medical use." This classification places cannabis alongside substances such as heroin and LSD, despite its widespread state-level medical programs and growing public support for reform.